Head-to-head study pits GSK’s drug combo against Roche’s Zelboraf

GlaxoSmithKline initiated a late-stage trial to evaluate the efficacy of experimental drugs dabrafenib and trametinib in pati -More- …
Read the full story: BIO SmartBrief